Clinical Trial Update: Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a dose-escalation study of TH-302 in combination with gemcitabine, docetaxel, or pemetrexed for advanced so…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Pancreatic Cancer
• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Gemcitabine (Gemcitabine)
• Pemetrexed (pemetrexed)
• TH-302 (evofosfamide)

Snippet

Sponsor: Threshold Pharmaceuticals | Conditions: Non-Small Cell Lung Cancer, Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED